MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

Vitestro

Corporate marketmedicalCurated record
vitestro.com

Vitestro develops Aletta®, the world's first Autonomous Robotic Phlebotomy Device (ARPD), which automates the entire diagnostic blood draw process. The system uses multimodal AI-powered Doppler ultrasound and imaging to identify suitable veins, then autonomously performs tourniquet application, skin prep, needle insertion, tube handling, and bandaging. Aletta achieved CE marking in 2024 and has been validated across 4,000+ patients with 94.5% first-stick success. The company is pursuing FDA De Novo clearance for US commercial entry.

HeadquartersUtrecht, NL
Founded2019
Corporate funding$70M
Team51-200
Deployments6
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries B
FoundersToon Overbeeke (Co-Founder), Brian Joseph (Co-Founder)
Regions servedEurope, North America
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Aletta

  • 94.5% first-stick success rate in clinical validation across 4,000+ patients

    Autonomous blood draw success on first needle insertion attempt, clinically validated against manual phlebotomy

    Claim source
  • CE marked for European hospital deployment (2024)

    European regulatory clearance enabling commercial deployment in EU hospitals

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2025-03-19Northwestern Medicinehospital / clinical trial siteUS2Announcement
2024-10-03Deventer ZiekenhuishospitalNL3Announcement
2024-05-21Odense University HospitalhospitalDK3Announcement
2024-04-03Result Laboratoriumclinical laboratoryNL2Announcement
2023-12-07St. Antonius HospitalhospitalNL2Announcement
2023-04-12OLVG Labclinical laboratoryNLNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordInvest-NLEIC FundLabcorp Venture FundMayo ClinicSutter HealthPGGM
TL

Company timeline

Milestones and announcements

2026-03-10Raised $70M oversubscribed Series B led by US healthcare strategic investors Labcorp, Mayo Clinic and Sutter HealthPR Newswire
2024-01-01Aletta® receives CE marking enabling European hospital deploymentVitestro
SC

Source ledger

8 unique public sources

01
Vitestro Raises $70 Million in Oversubscribed Series B FinancingPR Newswire · retrieved 2026-07-05
02
Vitestro Unveils Aletta®: The World's First Autonomous Robotic Phlebotomy Device™Vitestro · retrieved 2026-07-05
03
Northwestern Medicine and Vitestro Collaborate to Advance Autonomous Robotic PhlebotomyVitestro · retrieved 2026-07-05
04
Deventer Ziekenhuis schaft automatische bloedafnameapparaten aanDeventer Ziekenhuis · retrieved 2026-07-05
05
Danish hospital pre-orders 3 blood drawing devices, in first international deployment for VitestroVitestro · retrieved 2026-07-05
06
Vitestro secures order from Result Laboratorium for two blood drawing devicesVitestro · retrieved 2026-07-05
07
Dutch leading St. Antonius Hospital to deploy two Vitestro blood drawing devicesVitestro · retrieved 2026-07-05
08
Amsterdam-based OLVG Lab adopts Vitestro's autonomous blood drawing devicesPRNewswire · retrieved 2026-07-05